ctrl K

Watchlist Price Alert

Clarus Therapeutics Inc. (CRXT)

NASDAQ: CRXT · Real-Time Price · USD

0.05

-0.02 (-27.54%)

At close: Sep 06, 2022, 7:59 PM

Clarus Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020
Period Ending	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020
Revenue	19.24M	17.97M	13.96M	7.07M	5M	2.22M	2.22M	2.22M
Cost of Revenue	3.99M	3.38M	2.72M	1.06M	811K	257K	257K	257K
Gross Profit	15.25M	14.58M	11.24M	6M	4.19M	1.97M	1.97M	1.97M
Operating Income	-43.17M	-47.74M	-24.19M	-19.18M	-21.99M	-8.75M	-19.4M	-11.24M
Interest Income	3K	3K	2K	1K	1K	1K	1K	1K
Pretax Income	-48.07M	-55.49M	-29.97M	-10.24M	-2.06M	16.05M	5.41M	5.41M
Net Income	-58.62M	-64.02M	-36.54M	-10.24M	-2.06M	16.05M	5.41M	5.41M
Selling & General & Admin	60.81M	63.35M	47.34M	28.77M	29.61M	14.75M	14.75M	11.77M
Research & Development	5.13M	4.51M	3.63M	1.88M	2.04M	1.44M	1.44M	1.44M
Other Expenses	n/a	n/a	10.65M	10.65M	10.65M	10.65M	n/a	n/a
Operating Expenses	65.94M	67.86M	61.62M	41.3M	42.3M	26.84M	16.19M	13.21M
Interest Expense	15M	17.86M	15.89M	9.32M	9.17M	4.29M	4.29M	4.29M
Selling & Marketing Expenses	38.56M	41.41M	30.68M	17.08M	18.26M	8.73M	8.73M	8.73M
Cost & Expenses	69.93M	71.25M	64.34M	42.36M	43.11M	27.09M	16.45M	13.47M
Income Tax Expense	20.67M	18.65M	16.68M	10.11M	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	9.15M	9.15M	9.15M	9.15M	21.73M	3.48M	4.46M	21.73M
Shares Outstanding (Diluted)	9.15M	9.15M	9.15M	9.15M	21.73M	3.77M	4.46M	21.73M
EPS (Basic)	-6.4	-5.84	-0.94	1.93	2.48	3.31	0.25	0.25
EPS (Diluted)	-6.4	-5.84	-1.17	1.70	2.25	3.08	0.25	0.25
EBITDA	-32.43M	-22.67M	-9.12M	-7.35M	646.36K	1.54M	1.54M	9.7M
EBIT	-31.09M	-24.39M	-11.48M	1.68M	9.7M	9.7M	9.7M	9.7M
Depreciation & Amortization	39K	87.81K	136.02K	184.15K	21.11M	21.05M	21M	20.94M